Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vonoprazan for eradication of resistant Helicobacter pylori strains. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Ain Shams University | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED